Premium
Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients
Author(s) -
Erickson Jonathan,
McAuliffe William,
Blennerhassett Lewis,
Halbert Anne
Publication year - 2017
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13260
Subject(s) - medicine , sirolimus , vascular malformation , vascular anomaly , surgery
Fibroadipose vascular anomaly (FAVA) is a rare, complex mesenchymal malformation combining fibrofatty replacement of the affected muscles and slow‐flow vascular malformation. The condition is characterized by localized swelling, severe pain, phlebectasia, and contracture of the affected limb. Treatment paradigms are not well established for this rare, recently recognized condition. We report two cases of FAVA in which treatment with sirolimus produced rapid, dramatic improvement in pain and quality of life.